Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Eckmann

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Current Opinion in Infectious Diseases|January 19, 2016
The importance of source control in the management of severe skin and soft tissue infectionsChristian Eckmann
Deutsches Arzteblatt International|July 22, 2025
In ReplyChristian Eckmann
Current Opinion in Infectious Diseases|December 5, 2020
Cotrimoxazole and clindamycin in skin and soft tissue infectionsPhilippe Montravers, Christian Eckmann
Current Opinion in Infectious Diseases|December 5, 2020
Current management of necrotizing soft-tissue infectionsChristian Eckmann, Philippe Montravers
European Journal of Medical Research|December 18, 2010
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycinChristian Eckmann, M Dryden
Future Microbiology|September 30, 2016
ECCMID 2016: addressing the burden of recurrent Clostridium difficile infectionsChristian Eckmann, Sue Lyon
Intensive Care Medicine|December 6, 2013
Prognostic factors for mortality in (fecal) peritonitis: back to the roots!Christian Eckmann, Matteo Bassetti
Expert Opinion on Pharmacotherapy|December 23, 2014
Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infectionsChristian Eckmann, Joseph Solomkin
Infection|May 12, 2019
Essentials in the management of necrotizing soft-tissue infectionsNorma Jung, Christian Eckmann
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibioticsChristian Eckmann, Paul M Tulkens
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Current Opinion in Infectious Diseases|January 19, 2016
The importance of source control in the management of severe skin and soft tissue infectionsChristian Eckmann
Deutsches Arzteblatt International|July 22, 2025
In ReplyChristian Eckmann
Current Opinion in Infectious Diseases|December 5, 2020
Cotrimoxazole and clindamycin in skin and soft tissue infectionsPhilippe Montravers, Christian Eckmann
Current Opinion in Infectious Diseases|December 5, 2020
Current management of necrotizing soft-tissue infectionsChristian Eckmann, Philippe Montravers
European Journal of Medical Research|December 18, 2010
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycinChristian Eckmann, M Dryden
Future Microbiology|September 30, 2016
ECCMID 2016: addressing the burden of recurrent Clostridium difficile infectionsChristian Eckmann, Sue Lyon
Intensive Care Medicine|December 6, 2013
Prognostic factors for mortality in (fecal) peritonitis: back to the roots!Christian Eckmann, Matteo Bassetti
Expert Opinion on Pharmacotherapy|December 23, 2014
Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infectionsChristian Eckmann, Joseph Solomkin
Infection|May 12, 2019
Essentials in the management of necrotizing soft-tissue infectionsNorma Jung, Christian Eckmann
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibioticsChristian Eckmann, Paul M Tulkens
Pageof 8